ARCHIVES

NCI’s use of Cancer Dialogue for biospecimen network blueprint raises legal, procedural questions.

This article is from The Cancer Letter archive.

Vol. 29 No. 46 | December 12, 2003

Download PDF Visit The Full Archive

Related Articles

Phase III Trebananib Trial Fails OS Endpoint In Recurrent Platinum-Resistant Ovarian Cancer

November 28, 2014

ORI Finds St. Mary’s Data Managers Falsified Data In BCPT

September 8, 1995

Congressman Carter To Address ACCC Annual Conference

December 3, 1976

‘Helping Smokers Quit’ Program Launched By NCI, Pharmacist Group

June 27, 1986

Agricultural Pesticide Use Linked To Prostate Cancer

July 25, 2003

Majority Of Americans Support Cigarette Tax Increase, Survey Finds

May 28, 1993